Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region
作者： Jae-Hoon Song , Visanu Thamlikitkul , Po-Ren Hsueh , None
DOI: 10.1016/J.IJANTIMICAG.2011.02.017
关键词:
摘要: Community-acquired pneumonia (CAP) is an important cause of mortality and morbidity amongst adults in the Asia-Pacific region. Literature published between 1990 May 2010 on clinical economic burden CAP this region was reviewed. a significant health with impact Chronic obstructive pulmonary disease, cardiovascular diabetes mellitus advanced age were risk factors for CAP. Aetiological agents included Streptococcus pneumoniae, Klebsiella Gram-negative bacteria, Mycobacterium tuberculosis, Burkholderia pseudomallei, Staphylococcus aureus atypical pathogens (Mycoplasma Chlamydophila pneumoniae Legionella spp.), differences prevalence these within Antibiotic resistance but not linked to excess mortality. remained susceptible newer antimicrobial agents. Rational antibiotic use essential preventing resistance, increased surveillance required identify future trends incidence aetiology drive treatment prevention strategies.
elsevier.com
sci-hub.se 参考文章(128)
R. Lynfield, B. Beall, W. S. Schaffner, L. Harrison, A. Thomas, L. Lesher, J. Baumbach, M. M. Farley, J. Hadler, C. G. Whitney, A. Glennen, M. Deutscher, J. Jorgensen, A. Reingold, K. Gershman, M. Moore, G. L. Smith, Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae - United States, 2006-2007 Morbidity and Mortality Weekly Report. ,vol. 57, pp. 1353- 1355 ,(2008)
Sarah Moberley, John Holden, David Paul Tatham, Ross M Andrews, Vaccines for preventing pneumococcal infection in adults (Review) Cochrane Database of Systematic Reviews. ,vol. 2003, pp. 1- 55 ,(2003) , 10.1002/14651858.CD000422.PUB2
Nihon-Kokyuki-Gakkai, Nihon-kokyuki-gakkai-zasshi Soc.. ,(2011)
Wipa Reechaipichitkul, Veeradej Pisprasert, Severe community-acquired pneumonia (CAP) treated at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian Journal of Tropical Medicine and Public Health. ,vol. 35, pp. 430- 433 ,(2004)
Lim Tk, Lee Kh, Tan Wc, Chin Nk, Hospitalised low-risk community-acquired pneumonia: outcome and potential for cost-savings. Annals Academy of Medicine Singapore. ,vol. 28, pp. 389- 391 ,(1999)
Michael Baker, Guy Scott, Maria Turley, Helen Scott, Economic cost of community-acquired pneumonia in New Zealand adults. The New Zealand Medical Journal. ,vol. 117, ,(2004)
J Cutter, F L F Chan, S Ma, S K Chew, K T Goh, S Low, A national study of the epidemiology of pneumococcal disease among hospitalised patients in Singapore: 1995 to 2004. Singapore Medical Journal. ,vol. 48, pp. 824- 829 ,(2007)
Catherine J Dobbin, Christopher J Duggan, David J Barnes, The efficacy of an antibiotic protocol for community-acquired pneumonia. The Medical Journal of Australia. ,vol. 174, pp. 333- 337 ,(2001) , 10.5694/J.1326-5377.2001.TB143307.X
Hsi Hsun Lin, Yung Ching Liu, Susan Shin Jung Lee, Shue Ren Wann, Bor Shen Hu, Yao Shen Chen, Chun Kai Huang, Muh Yong Yen, Hung Chin Tsai, Yu Sen E Lin, A prospective etiologic study of community-acquired pneumonia in Taiwan Journal of the Formosan Medical Association. ,vol. 104, pp. 724- 730 ,(2005) , 10.29828/JFMA.200510.0004
A. B. Dey, K. M. Nagarkar, Vinod Kumar, Clinical presentation and predictors of outcome in adult patients with community-acquired pneumonia The National Medical Journal of India. ,vol. 10, pp. 169- 172 ,(1997)